what was classically defined as extrinsic allergic (IgE-mediated) asthma to intrinsic non-allergic asthma [2] . Recent genomic, transcriptomic and proteomic investigations of asthma, in combination with clinico-pathological parameters, have led to the realisation that clinically-diagnosed asthma encompasses a diverse and complex set of conditions referred to as 'endotypes' [3] [4] [5] . These range from classical allergic asthma (Th2-driven, IgE-mediated , eosinophilic), through neutrophilic asthma associated with the activation of innate immunity, to asthma involving little inflammation , but extensive airway remodelling [3] [4] [5] .
It has also become apparent that the traditional distinction between asthma and chronic obstructive pulmonary disease (COPD) is not always applicable, with some patients having features of both of these conditions [6] [7] [8] .
The majority of people with asthma display airflow obstruction that is episodic and returns to normal either spontaneously or following appropriate treatment. However, a minority of people with asthma display airflow obstruction that does not respond to treatment, i.e. can be described as 'fixed' ( [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] , reviewed in [23] ). This fixed airflow obstruction (FAO) is a feature more commonly associated with COPD [24] . It is not known why some asthma patients develop FAO. It may be a consequence of more severe asthma, duration of asthma, or it may represent a separate disease entirely. Far fewer studies have looked at the role that killer cells play in asthma with FAO. Immunohistochemistry has shown the degree of FAO to be significantly correlated to the number of CD8 T cells in bronchial biopsies [19] .
In this study, we have investigated the number and function of peripheral human killer cells in asthma with or without FAO to see if these differ, and to determine whether asthma with FAO is more similar to COPD or asthma without FAO in this respect.
Material and methods

Study population and procedures
The Nottingham Local Research Ethics Committee approved the study protocol (REC reference 10/H0405/2) and informed written consent was taken prior to subjects enrolling on to the study. Thirty individuals were recruited into three participant groups: asthma with fixed airflow obstruction (A+FAO), asthma without FAO (A-FAO), and healthy controls (H). All asthma subjects had a clinical diagnosis. Asthma patients with FAO had a post-bronchodilator FEV/FVC <0.7, despite clinician-optimised treatment [41] ; while asthma patients without FAO were age-matched, had no co-morbidities, were ex or non-smokers with a pack history of ≤10years, and had no infections within the previous six weeks. The demographic and spirometric data of the 30 study participants used to investigate killer cell number, surface receptor expression and intracellular cytotoxic mediator expression are shown in Table 1a ; details of the 20 participants whose MAPK signalling molecule expression were analysed are shown in Table 1b ; while the details of the 18 participants whose NK cell cytotoxicity levels were measured are shown in Table 1c .
Absolute cell counting
To quantify killer cell numbers, fluorescently labelled antibodies specific for several killer cell markers, shown in Table 2 , were added to 100µl whole peripheral blood at half the recommended concentration and left in the dark for 15 minutes. Optilyse C solution (Beckman Coulter, A11895) was used to lyse the red blood cells and was diluted with an equal volume of phosphate buffered saline (PBS, Sigma D8537) after 10 minutes. Finally, 100µl of flow-count fluorosphere beads (Beckman Coulter, 7547053) were added to each tube, before immediate analysis on a Beckman Coulter FC500 flow cytometer.
Peripheral blood mononuclear cell (PBMC) and killer cell isolation
To obtain PBMCs, peripheral whole blood was diluted to a ratio of 2:1 with RPMI-1640 media (Sigma, R8758), layered over histopaque (Sigma, H8889) and incubated with CD56 microbeads, washed, and passed through an MS column situated within a MACS magnet. After microbead release, using the supplied reagent, and another wash, the CD56 + fraction was incubated with CD3 microbeads; while the CD56 -fraction was incubated with CD8 microbeads. Both fractions were run through a fresh MS column, which yielded a CD56 + CD3 -fraction (NK cells), a CD56 + CD3 + fraction (NKT-like cells), and a CD56 -CD8 + fraction (CD8 T cells). All reagents and incubation steps were used and performed at 4 o C. A portion of each fraction was removed, stained extracellularly and analysed by flow cytometry to ascertain purity. The median CD8 T cell purity was above 92%, the median NK cell purity was above 97%, and the median NKT cell purity was above 74%.
Flow cytometry
Killer cell purity, surface receptor expression, and intracellular cytotoxic mediator expression were all analysed by flow cytometry. Briefly, cells were quick-fixed using a 3% formaldehyde fix solution. Those stained extracellularly were washed in phosphate buffered albumin (PBA-PBS (Oxoid BR0014G) with 1% BSA (Sigma A7284) and 0.1% NaN3 (Sigma S8032)), incubated with fluorescently-conjugated antibodies (see Table 2 ) for 30 minutes in the dark, and washed again. Those stained intracellularly were washed with 0.04% PBA-F o r P e e r R e v i e w O n l y 6 saponin (Sigma, S4521) followed by PBA-saponin with 10% FCS, before a twohour incubation and a final wash in PBA-saponin. All cells were stored in a 0.5% formaldehyde fix solution until analysis. Fluorescence-minus-one controls, containing all the antibodies bar one, were also included. Flow cytometry analysis was performed on a Beckman Coulter FC500 flow cytometer, with 50 000 events collected for each sample. Dead cells were excluded based on their forward (size) and side scatter (granularity).
Reverse-phase protein microarray (RPPA) analysis
An in-house cell lysate microarray system was used to quantify killer cell cytotoxic signalling molecule levels [42] . Briefly, samples were printed onto 16 pad nitrocellulose slides (Grace BioLabs) using a Microgrid II arraying robot (Digilab Inc., Marlborough, MA, USA). Slides were blocked, washed and probed with marker-specific rabbit antibodies (Cell Signaling Technology) and mouse anti-human β-actin control antibody (Sigma Aldrich, UK). Antibody binding was visualized by incubating with goat anti-mouse IR680 and goat anti-rabbit IR00 infrared secondary antibodies (Li-Cor BioSciences) diluted 1:5000 in 0.1% TBSTween for 30 minutes in the dark. Having been washed, rinsed with ultrapure water, and dried; the slides were scanned at 700nm and 800nm wavelengths on a Li-Cor Odyssey scanner (LI-COR Biosciences). Fluorescent signal for each feature (spot) was determined using Axon GenePix Pro software (Axon Instruments Inc.) Local background was subtracted and signals were normalized to β actin levels using the R statistical language and the RPPAnalyser 
Cytotoxicity assay
NK cell cytotoxicity was quantified using a non-radioactive LDH release assay kit (Promega, G1780) and the K562 human myelogenous leukaemia cell line (ECACC). The cell line was cultured in a 37 o C incubator using RPMI-1640 media (Sigma, R8758) with 10% FCS (HyClone, CH30160.03).
Kit instructions were followed. Briefly, the K562 and NK cells were 
Statistical analysis
Flow cytometry data were analysed using Weasel v2.7 software. The spot intensity of the microarray samples was measured using Genepix software, before RPPanalyzer software corrected for background, normalised to the actin signal of the same spot, and amplified the intensity of each spot. 
Results
Peripheral killer cell numbers
Peripheral CD8 T cell (CD8 + CD3 + CD56 -), NK cell (CD56 + CD3 -) and NKT-like cell (CD56 + CD3 + ) numbers were quantified using absolute cell counting (Fig. 1 ).
There were no statistically significant differences between the numbers or proportions of each killer cell type across the three participant groups (asthma patients with or without FAO and healthy controls).
Subsets of the killer cell types were also quantified using this method (data not shown). These subsets included: naïve (CD45RA + CCR7 + ), central memory (CM, CD45RA -CCR7 + ), effector memory (EM, CD45RA -CCR7 -) and effector T (Eff T, CD45RA + CCR7 -) CD8 T cells [43] ; CD56 dim (CD56 + /CD16 + ) and CD56 bright (CD56 ++ /CD16 -) NK cells [44] ; and CD4 -CD8 -, CD4 + CD8 -, CD4 -CD8 + and CD4 + CD8 + NKT-like cells [45] . Again, no significant differences were seen between the three participant groups for any of these subsets. 
Peripheral killer cell NKG2D and KIR3DL1 receptor expression
Peripheral killer cell ex vivo expression of the activatory NKG2D and inhibitory KIR3DL1 receptors was quantified using flow cytometry (Fig. 2) . No statistically significant differences were present between the participant groups for NKG2D or KIR3DL1 expression for any of the killer cell types.
The killer cell expression of a further four receptors (activatory KLRC2 and KIR2DS4, and inhibitory KLRD1 and KIR2DL2) was analysed by RPMA (data not shown). There were no significant differences in the expression of these four receptors between the participant groups for any of the killer cell types.
Peripheral killer cell cytotoxic signalling molecule expression
Peripheral CD8 T cells, NK cells and NKT-like cells were isolated (to purities of >92%, >97% and >74%, respectively), before their expression of total and phosphorylated ERK1/2, total and phosphorylated SAPK/JNK and total p38 MAPK was measured by RPMA and compared between asthma patients with and without FAO and healthy individuals ( Fig. 3 ). There were no significant differences in the expression of the aforementioned signalling molecules in the three isolated killer cell types.
Peripheral killer cell cytotoxic function
The peripheral killer cell ex vivo intracellular expression of the cytotoxic mediators perforin and granzyme B was analysed by flow cytometry and compared across the three participant groups (Fig. 4 ). There were no significant differences in the expression of either of these cytotoxic mediators between the participant groups for any of the three killer cell types. While most CD8 T cells (Fig. 4a) ; the majority of NK cells expressed both cytotoxic mediators (Fig. 4f) .
Peripheral NK cells were isolated to a purity of over 97%, before their cytotoxicity levels were quantified using the K562 cell line and a non-radioactive LDH release assay (Fig. 5 ). There were no statistically significant differences in NK cell cytotoxicity levels between the three participant groups.
Discussion
The work presented here shows that the number and function of killer cells in a small subset of asthma patients who display FAO are similar to those in asthma patients without FAO and in healthy controls. This is distinctly different from 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 F o r P e e r R e v i e w O n l y 11 FAO), whereas COPD patients were found to have significantly lower proportions of peripheral NK and NK-T cells than healthy controls (both never-smokers and smokers) [40] . A point of caution in drawing firm conclusions from the present results is the relatively small numbers of subjects in the healthy control, asthma without FAO and asthma with FAO groups, which limits the power of the study; although, having said that, similar numbers of subjects were used in our previous study that did show significant differences between peripheral killer cells in COPD patients and healthy controls [40] . However, it is clear that any differences in the number or proportions of killer cells between the healthy control, asthma without FAO and asthma with FAO groups are marginal, since power calculations showed that the numbers of subjects in each group required for 80% power would need to be 121 for the proportion of CD8 T cells, 468 for NK cell proportions and 84 for NKT-like cell proportions. Furthermore, modelling of the data in figure 1 with ten times more data points (but with the same distribution of data) still did not predict there to be any significant differences in killer cell numbers/proportions between the asthma patients without or with FAO.
In addition, no significant differences were observed in the proportion of peripheral CD8 T cells or NKT-like cells expressing both perforin and granzyme B between the three participant groups in the present study, whereas these proportions were found to be significantly decreased in COPD patients compared to healthy controls (both never-smokers and smokers) [40] . Again, despite the relatively small size of the healthy control, asthma without FAO and asthma with FAO groups in the present study, the lack of significant differences in the proportions of perforin + /granzyme-B + cells is supported by power calculations 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Furthermore, no significant differences were observed in the cytotoxic activity of peripheral NK cells between the three participant groups in the present study, whereas these cells were found to have significantly lower cytotoxic activity in COPD patients than in healthy controls (both never-smokers and smokers) [40] . However, the relatively small group sizes require there to be cautious interpretation of the data.
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